Nandrolone Phenylpropionate 100 - Genetic Pharmaceuticals

Released by Organon in 1959, nandrolone phenylpropionate—marketed as Durabolin—quickly became a staple in therapeutic anabolic steroid use. It was prescribed for treating anemia, advanced breast cancer, and muscle loss caused by chronic disease or trauma. With a fast-acting profile, it provided visible results within days, but its short half-life required frequent injections. Though later replaced by longer esters, Durabolin remained available in select countries and is still produced today in generic for

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Nandrolone Phenylpropionate 100 by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.